NEWS AND EVENTS
See what’s new with Oxidien, including our latest research, clinical trial news, and upcoming events.
Latest News
Oxidien Pharmaceuticals Announce Additions to New Strategic Advisory Board
GAINESVILLE, FL, USA, February 18, 2021 /EINPresswire.com/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced two additions to its newly...
Oxidien Pharmaceuticals Selected as Winner of Buzz of BIO in Early Stage Entrepreneur Category
Recognized as Early Stage Company with Ground-breaking TechnologyWinning Buzz of BIO gives us an additional boost going into BIO Investor Forum Digital where we will present this opportunity to potential new investors”— Helena CowleyGAINESVILLE, FL, USA, September 23,...
Oxidien Announces Publication of Clinical Results Demonstrating Significant Reduction in Urinary Oxalate
A Prospective, Double-Blind, Randomized, Placebo-Controlled, Cross-Over Study Using a Proprietary Orally Administered Oxalate Decarboxylase (OxDC)GAINESVILLE, FLA, USA, September 10, 2020 /EINPresswire.com/ -- Oxidien Pharmaceuticals, a clinical-stage...
OXIDIEN PHARMACEUTICALS ANNOUNCE ADDITION TO SCIENTIFIC AND MEDICAL ADVISORY BOARD
GAINESVILLE, FL, USA, July 9, 2020 /EINPresswire.com/ -- Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced three additions to its Scientific...
Oxidien in the top 3 at Life Science Nation’s RESI Innovation Challenge.
Oxidien in the top 3 at Life Science Nation’s RESI Innovation Challenge. Read More
Oxidien Chosen to Present at Venture Summit West
Oxidien Pharmaceuticals have been accepted to present at Venture Summit West organized by YoungStartup Ventures, the premier industry gathering connecting venture capitalists, corporate VCs, angel investors, technology transfer professionals, senior executives of...
OXIDIEN PHARMACEUTICALS TO PRESENT AT THE 2020 BIO CEO & INVESTOR CONFERENCE
Gainesville, Fla. (February 6, 2020) – Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an underserved kidney disease indication, today announced that it will present a corporate overview at the BIO...
Oxidien speaks to Christine Corrado with Proactive Investors at Biotech showcase 2020
https://www.youtube.com/watch?v=zXQTdjyhxfQ&feature=emb_logo
OXIDIEN PHARMACEUTICALS TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO
Gainesville, Fla. (January 6, 2020) – Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company developing a best-in-class enzyme therapeutic for an unmet kidney disease indication, today announced that it will present at Biotech Showcase™ 2020, to be held...